Evidence map›Paper›PMID 26865503›Full record

ArticleInternational journal of molecular medicine2016

Effects of ketanserin on experimental colitis in mice and macrophage function.

Junhua Xiao, Limei Shao, Jiaqing Shen, Weiliang Jiang, Yun Feng, Ping Zheng, Fei Liu

Open access · hybridAbstract read
In one paragraph

Article in International journal of molecular medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. The Role of Serotonin during Skin Healing in Post-Thermal Injury.International journal of molecular sciences · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Junhua XiaoDepartment of Gastroenterology, Shanghai East Hospital, Tongji University, Shanghai 200092, P.R. China.
Limei ShaoDepartment of Gastroenterology, Shanghai East Hospital, Tongji University, Shanghai 200092, P.R. China.
Jiaqing ShenDepartment of Gastroenterology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, P.R. China.
Weiliang JiangDepartment of Gastroenterology, Shanghai First People's Hospital, Shanghai Jiaotong University, Shanghai 200060, P.R. China.
Yun FengDepartment of Gastroenterology, Shanghai First People's Hospital, Shanghai Jiaotong University, Shanghai 200060, P.R. China.
Ping ZhengDepartment of Gastroenterology, Shanghai East Hospital, Tongji University, Shanghai 200092, P.R. China.
Fei LiuDepartment of Gastroenterology, Shanghai East Hospital, Tongji University, Shanghai 200092, P.R. China.
Shanghai East Hospital · CNShanghai First People's Hospital · CNFirst Affiliated Hospital of Soochow University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ketanserin is a selective 5-hydroxytryptamine (serotonin)-2A receptor (5-HT2AR) antagonist. Studies have suggested that ketanserin exerts anti-inflammatory effects independent of the baroreflex; however, the mechanisms involved remain unclear. Thus, in the present study, we aimed to evaluate the effects of ketanserin in colitis and the possible underlying mechanisms. The expression of 5-HT2AR was assessed in the colon tissues of patients with inflammatory bowel disease (IBD) and in mice with dextran sodium sulfate (DSS)-induced colitis. The therapeutic potential of ketanserin was investigated in the mice with colitis. In the colon tissue samples from the patients with IBD, a high expression level of 5-HT2AR was observed. Treatment with ketanserin attenuated the progression of experimental colitis in the mice, as indicated by body weight assessment, colon length, histological scores and cytokine release. The colonic macrophages from the ketanserin-treated mice with colitis exhibited a decreased production of inflammatory cytokines, with M2 polarization and impaired migration. The knockdown of 5-HT2AR using siRNA partly abolished the inhibitory effects of ketanserin on the release of pro-inflammatory cytokines in bone marrow derived-macrophages (BMDMs), thus demonstrating that the inhibitory effects of ketanserin on the production of inflammatory cytokines are partly dependent on 5-HT2AR. Ketanserin also inhibited the activation of nuclear factor-κB (NF-κB) in BMDMs. In conclusion, the findings of the present study demonstrate that ketanserin alleviates colitis. Its anti-inflammatory effects may be due to the promotion of the anti-inflammatory function of macrophages through 5-HT2AR/NF-κB.

Indexed as

AnimalsColitisDextran SulfateDisease Models, AnimalHumansKetanserinMacrophagesMaleMiceMice, Inbred C57BLNF-kappa BReceptor, Serotonin, 5-HT2ARNA, Small InterferingDextran SulfateKetanserinNF-kappa BReceptor, Serotonin, 5-HT2ARNA, Small Interfering

Identifiers

PMID26865503
PMCPMC4771115
OpenAlexW2269482850

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.